Shanghai Sigma-Audley New Material Technology: difference between revisions
Diff·revision 20 → 21·20:13, 30 Jul 2025
Difference between revision 20 and revision 21 of Shanghai Sigma-Audley New Material Technology. 14 lines changed; the page grew by 1,494 bytes.
| Revision 20 — 02:55, 10 Jul 2025 Retention_Time_Rae (talk) typo 10,600 bytes ±0 | Revision 21 — 20:13, 30 Jul 2025 TFA_Counterion (talk) fix a broken wikilink 12,094 bytes +1,494 | ||
|---|---|---|---|
| 71 | '''The one check that needs no equipment''' is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See [[Lot traceability]]. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page. | 71 | '''The one check that needs no equipment''' is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See [[Lot traceability]]. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page. |
| 72 | 72 | ||
| + | 73 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. | |
| + | 74 | ||
| 73 | == Reception == | 75 | == Reception == |
| 74 | The PeptidePedia tally records 889 self-reported submissions to July 2026. What recurs across them is packaging and delivery consistency: submissions repeatedly describe the same secondary packing, the same desiccant arrangement and the same transit windows across orders months apart, which is the attribute this community has found most consistently reported for SSA.{{r|tally}} The tally is self-selected and measures reception rather than quality.{{r|tally}} | 76 | The PeptidePedia tally records 889 self-reported submissions to July 2026. What recurs across them is packaging and delivery consistency: submissions repeatedly describe the same secondary packing, the same desiccant arrangement and the same transit windows across orders months apart, which is the attribute this community has found most consistently reported for SSA.{{r|tally}} The tally is self-selected and measures reception rather than quality.{{r|tally}} |
| 75 | 77 | ||
| + | 78 | === How this tally should be read === | |
| + | 79 | The reception figure above is a count of self-reported submissions to PeptidePedia, not a score: this wiki publishes none, and the figure says how many people wrote in rather than how good anything is. It is '''weak evidence''' and is subject to three limitations that apply to every such figure on this wiki: | |
| + | 80 | ||
| + | 81 | * '''Self-selection.''' People who submit are not a sample of purchasers. Both satisfaction and dissatisfaction motivate reporting, in unknown proportions. | |
| + | 82 | * '''It measures reception, not quality.''' Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly. | |
| + | 83 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} | |
| + | 84 | ||
| 76 | == References == | 85 | == References == |
| 77 | {{reflist}} | 86 | {{reflist}} |
| ⋮ | ⋮ | ||
| 84 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> | 93 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> |
| 85 | 94 | ||
| + | 95 | == Further reading == | |
| + | 96 | * [[Project:Vendor notability]] — the criteria under which this article exists, and what supplier articles may not contain. | |
| + | 97 | * [[Project:Sourcing guidelines]] — how test reports and community tallies are cited on this wiki. | |
| + | 98 | ||
| 86 | == See also == | 99 | == See also == |
| 87 | * [[Certificate of analysis]] | 100 | * [[Certificate of analysis]] |
| ⋮ | ⋮ | ||
| 91 | * [[Research use only]] | 104 | * [[Research use only]] |
| 92 | * [[Peptide supply chain]] | 105 | * [[Peptide supply chain]] |
| + | 106 | * [[Blind sampling]] | |
| 93 | 107 | ||
| 94 | {{DEFAULTSORT:Shanghai Sigma-Audley New Material Technology}} | 108 | {{DEFAULTSORT:Shanghai Sigma-Audley New Material Technology}} |